Vyome Holdings (HIND) Share-based Compensation (2015 - 2026)
Vyome Holdings (HIND) posted quarterly Share-based Compensation of $5696.0 for Q1 2026, up 100.3% quarter-over-quarter from -$1.9 million in Q4 2025.
Vyome Holdings (HIND) Share-based Compensation (2015 - 2026) Analysis & Trends
Vyome Holdings' Share-based Compensation history runs 12 years deep, the most recent figure standing at $5696.0 for Q1 2026.
- In Q1 2026, Share-based Compensation changed N/A year-over-year to $5696.0; the TTM figure through Mar 2026 stood at -$1.3 million (down 947.75% YoY), while the FY2025 annual figure was $577128.0, up 213.66% from the prior year.
- Share-based Compensation for Q1 2026 stood at $5696.0, up from -$1.9 million in the prior quarter.
- The five-year high for Share-based Compensation was $770000.0 in Q2 2022, with the low at -$1.9 million in Q4 2025.
- The 5-year median for Share-based Compensation is $91000.0 (2023), against an average of -$1161.2.
- Peak annual rise in Share-based Compensation reached 1588.56% in 2025, while the deepest fall reached 12635.9% in 2025.
- Vyome Holdings' Share-based Compensation stood at -$1.5 million in 2022, then soared by 107.19% to $110000.0 in 2023, then sank by 86.36% to $15000.0 in 2024, then plunged by 12635.9% to -$1.9 million in 2025, then jumped by 100.3% to $5696.0 in 2026.
- Business Quant data shows HIND's Share-based Compensation at $5696.0 in Q1 2026, -$1.9 million in Q4 2025, and $574109.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.70 Bn | 131.85 Bn | 2.84 Bn | 108.10 Mn |
| 2 | Regeneron Pharmaceuticals | 86.74 Bn | 78.75 Bn | 3.93 Bn | 243.00 Mn |
| 3 | Argenx Se | 65.36 Bn | 60.18 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.15 Bn | 54.01 Bn | 52.00 Mn | 120.00 Mn |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn | 137.41 Mn |
| 6 | Alnylam Pharmaceuticals | 31.88 Bn | 28.57 Bn | 992.69 Mn | 86.63 Mn |
| 7 | BioNTech SE | 28.14 Bn | 9.75 Bn | 668.28 Mn | 28.05 Mn |
| 8 | Insmed | 27.59 Bn | 26.43 Bn | 358.27 Mn | 41.25 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.48 Bn | - | - |
| 10 | Vyome Holdings | 16.00 Mn | 8.11 Mn | 11,658.00 | 11,051.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11,051.00 |
| Jun 30, 2026 | 11,051.00 |
| Mar 31, 2026 | 5,696.00 |
| Mar 31, 2026 | 5,696.00 |
| Dec 31, 2025 | -1.88 Mn |
| Dec 31, 2025 | -1.88 Mn |
| Sep 30, 2025 | 574,109.00 |
| Sep 30, 2025 | 574,109.00 |
| Jun 30, 2025 | 12,000.00 |
| Jun 30, 2025 | 12,000.00 |
| Dec 31, 2024 | 15,000.00 |
| Dec 31, 2024 | 15,000.00 |
| Sep 30, 2024 | 34,000.00 |
| Sep 30, 2024 | 34,000.00 |
| Jun 30, 2024 | 65,000.00 |
| Jun 30, 2024 | 65,000.00 |
| Mar 31, 2024 | 72,000.00 |
| Mar 31, 2024 | 72,000.00 |
| Dec 31, 2023 | 110,000.00 |
| Dec 31, 2023 | 110,000.00 |